Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria

Kristina A. Strnadová, Felix Votava, Jan Lebl, Adolf Mühl, Chike Item, Olaf A. Bodamer, Toni Torresani, Ivan Bouška, Franz Waldhauser, Wolfgang Sperl

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

This study aimed to estimate the number of infants who died of unrecognized congenital adrenal hyperplasia (CAH) in Austria and the Czech Republic within the past 13 years, before the introduction of adequate neonatal screening. The study was based on retrospective analysis of neonatal screening cards of 242 infants who died suddenly between 7 days and 12 months of age and whose cause of death could not be identified. 17-hydroxyprogesterone (17-OHP) was measured by fluoroimmunoassay and positive samples were subsequently genotyped. Three infants out of 242 may have had unrecognized CAH due to CYP21 (steroid 21-hydroxylase) gene defect. Their newborn 17-OHP levels and CYP21 genotypes were 706 nmol/l and del/conv//del/conv, 53 nmol/l and I2//I2, and 811 nmol/l and I2//Gln318stop, respectively. CAH due to CYP21 defect can lead to sudden unexpected death without prior symptoms typical for the condition. Hence, newborn screening would have prevented these deaths had it been available. In addition, we have shown that the I2 point mutation that is expected to lead to simple virilizing form may lead to a fatal outcome.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalEuropean Journal of Pediatrics
Volume166
Issue number1
DOIs
StatePublished - Jan 1 2007

Fingerprint

Congenital Adrenal Hyperplasia
Sudden Infant Death
Austria
Czech Republic
Neonatal Screening
Newborn Infant
Fluoroimmunoassay
17-alpha-Hydroxyprogesterone
Steroid 21-Hydroxylase
Fatal Outcome
Sudden Death
Point Mutation
Cause of Death
Genotype
Genes

Keywords

  • Congenital adrenal hyperplasia
  • Neonatal screening
  • Sudden infant death syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Strnadová, K. A., Votava, F., Lebl, J., Mühl, A., Item, C., Bodamer, O. A., ... Sperl, W. (2007). Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria. European Journal of Pediatrics, 166(1), 1-4. https://doi.org/10.1007/s00431-006-0154-8

Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria. / Strnadová, Kristina A.; Votava, Felix; Lebl, Jan; Mühl, Adolf; Item, Chike; Bodamer, Olaf A.; Torresani, Toni; Bouška, Ivan; Waldhauser, Franz; Sperl, Wolfgang.

In: European Journal of Pediatrics, Vol. 166, No. 1, 01.01.2007, p. 1-4.

Research output: Contribution to journalArticle

Strnadová, KA, Votava, F, Lebl, J, Mühl, A, Item, C, Bodamer, OA, Torresani, T, Bouška, I, Waldhauser, F & Sperl, W 2007, 'Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria', European Journal of Pediatrics, vol. 166, no. 1, pp. 1-4. https://doi.org/10.1007/s00431-006-0154-8
Strnadová, Kristina A. ; Votava, Felix ; Lebl, Jan ; Mühl, Adolf ; Item, Chike ; Bodamer, Olaf A. ; Torresani, Toni ; Bouška, Ivan ; Waldhauser, Franz ; Sperl, Wolfgang. / Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria. In: European Journal of Pediatrics. 2007 ; Vol. 166, No. 1. pp. 1-4.
@article{a53339ec09884799b96898a8aa2e0709,
title = "Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria",
abstract = "This study aimed to estimate the number of infants who died of unrecognized congenital adrenal hyperplasia (CAH) in Austria and the Czech Republic within the past 13 years, before the introduction of adequate neonatal screening. The study was based on retrospective analysis of neonatal screening cards of 242 infants who died suddenly between 7 days and 12 months of age and whose cause of death could not be identified. 17-hydroxyprogesterone (17-OHP) was measured by fluoroimmunoassay and positive samples were subsequently genotyped. Three infants out of 242 may have had unrecognized CAH due to CYP21 (steroid 21-hydroxylase) gene defect. Their newborn 17-OHP levels and CYP21 genotypes were 706 nmol/l and del/conv//del/conv, 53 nmol/l and I2//I2, and 811 nmol/l and I2//Gln318stop, respectively. CAH due to CYP21 defect can lead to sudden unexpected death without prior symptoms typical for the condition. Hence, newborn screening would have prevented these deaths had it been available. In addition, we have shown that the I2 point mutation that is expected to lead to simple virilizing form may lead to a fatal outcome.",
keywords = "Congenital adrenal hyperplasia, Neonatal screening, Sudden infant death syndrome",
author = "Strnadov{\'a}, {Kristina A.} and Felix Votava and Jan Lebl and Adolf M{\"u}hl and Chike Item and Bodamer, {Olaf A.} and Toni Torresani and Ivan Bouška and Franz Waldhauser and Wolfgang Sperl",
year = "2007",
month = "1",
day = "1",
doi = "10.1007/s00431-006-0154-8",
language = "English",
volume = "166",
pages = "1--4",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria

AU - Strnadová, Kristina A.

AU - Votava, Felix

AU - Lebl, Jan

AU - Mühl, Adolf

AU - Item, Chike

AU - Bodamer, Olaf A.

AU - Torresani, Toni

AU - Bouška, Ivan

AU - Waldhauser, Franz

AU - Sperl, Wolfgang

PY - 2007/1/1

Y1 - 2007/1/1

N2 - This study aimed to estimate the number of infants who died of unrecognized congenital adrenal hyperplasia (CAH) in Austria and the Czech Republic within the past 13 years, before the introduction of adequate neonatal screening. The study was based on retrospective analysis of neonatal screening cards of 242 infants who died suddenly between 7 days and 12 months of age and whose cause of death could not be identified. 17-hydroxyprogesterone (17-OHP) was measured by fluoroimmunoassay and positive samples were subsequently genotyped. Three infants out of 242 may have had unrecognized CAH due to CYP21 (steroid 21-hydroxylase) gene defect. Their newborn 17-OHP levels and CYP21 genotypes were 706 nmol/l and del/conv//del/conv, 53 nmol/l and I2//I2, and 811 nmol/l and I2//Gln318stop, respectively. CAH due to CYP21 defect can lead to sudden unexpected death without prior symptoms typical for the condition. Hence, newborn screening would have prevented these deaths had it been available. In addition, we have shown that the I2 point mutation that is expected to lead to simple virilizing form may lead to a fatal outcome.

AB - This study aimed to estimate the number of infants who died of unrecognized congenital adrenal hyperplasia (CAH) in Austria and the Czech Republic within the past 13 years, before the introduction of adequate neonatal screening. The study was based on retrospective analysis of neonatal screening cards of 242 infants who died suddenly between 7 days and 12 months of age and whose cause of death could not be identified. 17-hydroxyprogesterone (17-OHP) was measured by fluoroimmunoassay and positive samples were subsequently genotyped. Three infants out of 242 may have had unrecognized CAH due to CYP21 (steroid 21-hydroxylase) gene defect. Their newborn 17-OHP levels and CYP21 genotypes were 706 nmol/l and del/conv//del/conv, 53 nmol/l and I2//I2, and 811 nmol/l and I2//Gln318stop, respectively. CAH due to CYP21 defect can lead to sudden unexpected death without prior symptoms typical for the condition. Hence, newborn screening would have prevented these deaths had it been available. In addition, we have shown that the I2 point mutation that is expected to lead to simple virilizing form may lead to a fatal outcome.

KW - Congenital adrenal hyperplasia

KW - Neonatal screening

KW - Sudden infant death syndrome

UR - http://www.scopus.com/inward/record.url?scp=33845435206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845435206&partnerID=8YFLogxK

U2 - 10.1007/s00431-006-0154-8

DO - 10.1007/s00431-006-0154-8

M3 - Article

C2 - 17024350

AN - SCOPUS:33845435206

VL - 166

SP - 1

EP - 4

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 1

ER -